Search research articles
Contact Us
Filters
Showing results (231-240 of 265) with videos related to
Page
of 27
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 15, 2004
A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen
S R D Johnston, L A Gumbrell, T R J Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2024
Global diversity of enterococci and description of 18 previously unknown species
Julia A Schwartzman, Francois Lebreton, Rauf Salamzade, et al.
The New England Journal of Medicine
|
November 3, 2006
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J Poole, Helena M Earl, Louise Hiller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients
H R Ali, E Provenzano, S-J Dawson, et al.
Nature Medicine
|
November 27, 2019
Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination
Roby P Bhattacharyya, Nirmalya Bandyopadhyay, Peijun Ma, et al.
European Journal of Radiology Open
|
April 30, 2019
Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer
Surrin S Deen, Frank Riemer, Mary A McLean, et al.
The New England Journal of Medicine
|
August 9, 2013
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome
Ami S Bhatt, Samuel S Freeman, Alex F Herrera, et al.
Lancet (London, England)
|
December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
Andrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Nature Microbiology
|
May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women
Colin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Cell
|
May 1, 2026
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut
Luisella Spiga, Ryan T Fansler, Yifan Wu, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 265) with videos related to
Sort By:
Page
of 27
Cancer Chemotherapy and Pharmacology
|
January 15, 2004
A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen
S R D Johnston, L A Gumbrell, T R J Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2024
Global diversity of enterococci and description of 18 previously unknown species
Julia A Schwartzman, Francois Lebreton, Rauf Salamzade, et al.
The New England Journal of Medicine
|
November 3, 2006
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J Poole, Helena M Earl, Louise Hiller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients
H R Ali, E Provenzano, S-J Dawson, et al.
Nature Medicine
|
November 27, 2019
Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination
Roby P Bhattacharyya, Nirmalya Bandyopadhyay, Peijun Ma, et al.
European Journal of Radiology Open
|
April 30, 2019
Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer
Surrin S Deen, Frank Riemer, Mary A McLean, et al.
The New England Journal of Medicine
|
August 9, 2013
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome
Ami S Bhatt, Samuel S Freeman, Alex F Herrera, et al.
Lancet (London, England)
|
December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
Andrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Nature Microbiology
|
May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women
Colin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Cell
|
May 1, 2026
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut
Luisella Spiga, Ryan T Fansler, Yifan Wu, et al.
Page
of 27